Zurcher Kantonalbank (Zurich Cantonalbank) United Therapeutics Corp Transaction History

Zurcher Kantonalbank (Zurich Cantonalbank)

$32.8 Billion
Q3 2024

A detailed history of Zurcher Kantonalbank (Zurich Cantonalbank) transactions in United Therapeutics Corp stock. As of the latest transaction made, Zurcher Kantonalbank (Zurich Cantonalbank) holds 29,123 shares of UTHR stock, worth $10.6 Million. This represents 0.03% of its overall portfolio holdings.

Number of Shares

29,123

Previous 29,123 -0.0%

Holding current value

$10.6 Million

Previous $10.4 Million -0.0%

% of portfolio

0.03%

Previous 0.03%

23 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 07, 2024	SELL	$311.04 - $363.55 $1.5 Million - $1.75 Million	-4,820 Reduced 14.2%	29,123 $10.4 Million
Q2 2024 Jul 29, 2024	BUY	$228.26 - $319.04 $2.02 Million - $2.82 Million	8,833 Added 35.18%	33,943 $10.8 Million
Q1 2024 Apr 25, 2024	BUY	$210.76 - $249.51 $832,080 - $985,065	3,948 Added 18.66%	25,110 $5.77 Million
Q4 2023 Jan 30, 2024	BUY	$214.88 - $256.94 $2.82 Million - $3.37 Million	13,130 Added 163.47%	21,162 $4.65 Million
Q3 2023 Oct 25, 2023	SELL	$211.82 - $248.24 $4,024 - $4,716	-19 Reduced 0.24%	8,032 $1.81 Million
Q2 2023 Aug 07, 2023	BUY	$205.19 - $232.99 $32,625 - $37,045	159 Added 2.01%	8,051 $1.78 Million
Q1 2023 May 08, 2023	BUY	$212.99 - $276.17 $249,624 - $323,671	1,172 Added 17.44%	7,892 $1.77 Million
Q4 2022 Feb 01, 2023	BUY	$205.95 - $280.43 $158,375 - $215,650	769 Added 12.92%	6,720 $1.87 Million
Q3 2022 Nov 09, 2022	BUY	$203.3 - $244.17 $43,099 - $51,764	212 Added 3.69%	5,951 $1.25 Million
Q2 2022 Aug 09, 2022	SELL	$174.81 - $241.14 $66,078 - $91,150	-378 Reduced 6.18%	5,739 $1.35 Million
Q1 2022 Apr 21, 2022	SELL	$166.16 - $213.96 $121,462 - $156,404	-731 Reduced 10.67%	6,117 $1.1 Million
Q4 2021 Feb 01, 2022	BUY	$184.32 - $216.08 $304,865 - $357,396	1,654 Added 31.84%	6,848 $1.48 Million
Q3 2021 Nov 15, 2021	SELL	$179.86 - $214.88 $124,822 - $149,126	-694 Reduced 11.79%	5,194 $959,000
Q2 2021 Jul 30, 2021	BUY	$170.47 - $211.93 $75,177 - $93,461	441 Added 8.1%	5,888 $1.06 Million
Q1 2021 May 03, 2021	BUY	$153.94 - $174.85 $923 - $1,049	6 Added 0.11%	5,447 $911,000
Q4 2020 Jan 28, 2021	BUY	$101.87 - $151.79 $60,103 - $89,556	590 Added 12.16%	5,441 $826,000
Q2 2020 Jul 28, 2020	BUY	$92.74 - $125.82 $112,957 - $153,248	1,218 Added 33.53%	4,851 $587,000
Q1 2020 May 06, 2020	BUY	$79.39 - $115.35 $29,691 - $43,140	374 Added 11.48%	3,633 $344,000
Q4 2019 Jan 21, 2020	BUY	$78.31 - $95.34 $36,962 - $45,000	472 Added 16.94%	3,259 $287,000
Q3 2019 Oct 18, 2019	BUY	$74.85 - $85.99 $42,664 - $49,014	570 Added 25.71%	2,787 $222,000
Q2 2019 Jul 30, 2019	SELL	$76.06 - $120.81 $361,285 - $573,847	-4,750 Reduced 68.18%	2,217 $173,000
Q4 2017 Jan 31, 2018	SELL	$118.58 - $151.28 $138,501 - $176,695	-1,168 Reduced 14.36%	6,967 $1.03 Million
Q3 2017 Nov 08, 2017	BUY	$114.6 - $136.81 $932,271 - $1.11 Million	8,135	8,135 $953,000

Others Institutions Holding UTHR

# of Institutions

673

Shares Held

42.2M

Call Options Held

194K

Put Options Held

295K

View Full List

About UNITED THERAPEUTICS Corp

Ticker UTHR
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 45,516,300
Market Cap $16.6B
Description
United Therapeutics Corporation, a biotechnology company, engages in the development and commercialization of products to address the unmet medical needs of patients with chronic and life-threatening diseases in the United States and internationally. Its commercial therapies include Remodulin to treat patients with pulmonary arterial hypertensio...

More about UTHR

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Zurcher Kantonalbank (Zurich Cantonalbank), based on Form 13F filings with the SEC.

News

Stay updated on Zurcher Kantonalbank (Zurich Cantonalbank) with notifications on news.

Account

Zurcher Kantonalbank (Zurich Cantonalbank) United Therapeutics Corp Transaction History